Nanting Chen
Biographic Data
| ID | 9400462 |
|---|---|
| NAME | Nanting Chen |
| GIVEN NAMES | Nanting |
| FAMILY NAME | Chen |
| SIGNATURE | CHEN N |
| AFFILIATIONS | Dalian Medical University |
| ORCID | 0009-0008-8801-8518 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Comparing the trends of cancer burden attributed to high BMI in China and globally from 1990 to 2021, with multi-model prediction to 2036
Introduction: High body mass index (BMI) has been identified as a significant contributor to cancers. However, details regarding the evolution of the cancer burden attributable to high BMI in China have not been available. With the epidemic of high BMI among Chinese recent years, it's essential to evaluate the disease burden of cancer associated with high BMI to guide disease interventions and enhance public health. This study aimed to evaluate t…
Global burden of pulmonary arterial hypertension and health inequality in women of childbearing age from 1990 to 2021, with projections up to 2040
Objective: To assess the global burden, trends, and inequalities of pulmonary arterial hypertension (PAH) among women of childbearing age (WCBA) from 1990 to 2021, projecting future trends to 2040. Methods: Using Global Burden of Disease (GBD) 2021 data, we analyzed PAH mortality, incidence, prevalence, and disability-adjusted life years (DALYs) among WCBA aged 15 to 49. Trends were assessed via age-standardized rates (ASR), estimated annual perc…
QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPARγ-LXRα/β-Abca1 pathway
The anti-atherosclerotic mechanism of QSYQ was involved in inhibiting lipid phagocytosis and promoting reverse cholesterol transport, therefore reducing lipid deposition and inflammatory cells in plaque.
No prominent works on this page.
QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPARγ-LXRα/β-Abca1 pathway
The anti-atherosclerotic mechanism of QSYQ was involved in inhibiting lipid phagocytosis and promoting reverse cholesterol transport, therefore reducing lipid deposition and inflammatory cells in plaque.
Comparing the trends of cancer burden attributed to high BMI in China and globally from 1990 to 2021, with multi-model prediction to 2036
Introduction: High body mass index (BMI) has been identified as a significant contributor to cancers. However, details regarding the evolution of the cancer burden attributable to high BMI in China have not been available. With the epidemic of high BMI among Chinese recent years, it's essential to evaluate the disease burden of cancer associated with high BMI to guide disease interventions and enhance public health. This study aimed to evaluate t…
Global burden of pulmonary arterial hypertension and health inequality in women of childbearing age from 1990 to 2021, with projections up to 2040
Objective: To assess the global burden, trends, and inequalities of pulmonary arterial hypertension (PAH) among women of childbearing age (WCBA) from 1990 to 2021, projecting future trends to 2040. Methods: Using Global Burden of Disease (GBD) 2021 data, we analyzed PAH mortality, incidence, prevalence, and disability-adjusted life years (DALYs) among WCBA aged 15 to 49. Trends were assessed via age-standardized rates (ASR), estimated annual perc…
Medicine (2 works) · ABCA1 (1 work) · Aorta (1 work) · Aspirin (1 work) · Biochemistry (1 work) · Biology (1 work) · Body mass index (1 work) · Burden of disease (1 work) · Cancer (1 work) · Cancer Risks and Factors (1 work)